Your browser doesn't support javascript.
loading
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.
Matsubara, Nobuaki; Nagamori, Satsohi; Wakumoto, Yoshiaki; Uemura, Hirotsugu; Kimura, Go; Yokomizo, Akira; Kikukawa, Hiroaki; Mizokami, Atsushi; Kosaka, Takeo; Masumori, Naoya; Kawasaki, Yoshihide; Yonese, Junji; Nasu, Yasutomo; Fukasawa, Satoshi; Sugiyama, Takayuki; Kinuya, Seigo; Hosono, Makoto; Yamaguchi, Iku; Tsutsui, Hirokazu; Uemura, Hiroji.
Affiliation
  • Matsubara N; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, 277-8577, Japan. nmatsuba@east.ncc.go.jp.
  • Nagamori S; Department of Urology, National Hospital Organization Hokkaido Cancer Center, 2-3-54 Kikusui 4 Jo, Shiroishi-ku, Sapporo, Japan.
  • Wakumoto Y; Department of Urology, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan.
  • Uemura H; Department of Urology, Kindai University Faculty of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Japan.
  • Kimura G; Department of Urology, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan.
  • Yokomizo A; Department of Urology, Harasanshin Hospital, 1-8, Taihakumachi, Hakata-ku, Fukuoka, Japan.
  • Kikukawa H; Department of Urology, National Hospital Organization Kumamoto Medical Center, 1-5 Ninomaru, Chuo-ku, Kumamoto, Japan.
  • Mizokami A; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Japan.
  • Kosaka T; Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
  • Masumori N; Department of Urology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Japan.
  • Kawasaki Y; Department of Urology, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, Japan.
  • Yonese J; Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, Japan.
  • Nasu Y; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1, Shikata, Okayama, Japan.
  • Fukasawa S; Prostate Center and Division of Urology, Chiba Cancer Center, 666-2, Nitona-cho, Chuo-ku, Chiba, Japan.
  • Sugiyama T; Department of Urology, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Japan.
  • Kinuya S; The Japanese Society of Nuclear Medicine, 2-28-45, Honkomagome, Bunkyo-ku, Tokyo, Japan.
  • Hosono M; The Japanese Society of Nuclear Medicine, 2-28-45, Honkomagome, Bunkyo-ku, Tokyo, Japan.
  • Yamaguchi I; Clinical Statistics, Bayer Yakuhin, Ltd, 2-4-9, Umeda, Kita-ku, Osaka, Japan.
  • Tsutsui H; Clinical Development Specialty Medicine, Bayer Yakuhin, Ltd, 2-4-9, Umeda, Kita-ku, Osaka, Japan.
  • Uemura H; Department of Urology, Yokohama City University Medical Center, 4-57, Urafune-cho, Minami-ku, Yokohama, Japan.
Int J Clin Oncol ; 23(1): 173-180, 2018 Feb.
Article in En | MEDLINE | ID: mdl-28770408
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Radium / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Radium / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: Japan